Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Germ Cell and Embryonal × Bevacizumab × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 49 Ovarian Neoplasms 29 Carcinoma, Hepatocellular 24 Neoplasms 16 Carcinoma, Non-Small-Cell Lung 16 Fallopian Tube Neoplasms 15 Colonic Neoplasms 10 Breast Neoplasms 9 Uterine Cervical Neoplasms 8 Liver Neoplasms 8 Rectal Neoplasms 7 Lung Neoplasms 7 Glioblastoma 7 Endometrial Neoplasms 7 Brain Neoplasms 7 Neoplasm Metastasis 6 Triple Negative Breast Neoplasms 5 Stomach Neoplasms 5 Recurrence 5 Carcinoma, Renal Cell 5 Carcinoma, Ovarian Epithelial 5 Small Cell Lung Carcinoma 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Colorectal Cancer Metastatic 4 Advanced Solid Tumors 4 Squamous Cell Carcinoma of Head and Neck 3 Medulloblastoma 3 Gastrointestinal Neoplasms 3 Digestive System Neoplasms 3 Carcinoma, Pancreatic Ductal 3

Interventions

fludarabine 3 Cyclophosphamide 3 fludarabine phosphate 2 Sirolimus 2 Etoposide 2 Cisplatin 2 Carboplatin 2 tremelimumab 1 pralsetinib 1 pembrolizumab 1 etoposide phosphate 1 durvalumab 1 cabozantinib 1 Surveys and Questionnaires 1 Stem Cell Transplantation 1 Standard of Care 1 Specimen Handling 1 Respiratory Physiological Phenomena 1 Proton Therapy 1 Practice Guidelines as Topic 1 Platinum 1 Pemetrexed 1 Paclitaxel 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Celecoxib 1 Busulfan 1 Bleomycin 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡